20.08.2020 • NewsShell

Shell Plans Indian Petchems JV

Shell is planning to take a 50% stake and invest up to $9 billion in a petrochemical complex planned by privately held Indian oil company Nayara Energy, according to Reuters news agency.

Quoting sources familiar with the matter, Reuters said the two companies signed a Memorandum of Understanding in June to establish a joint venture. Shell has not commented on the story.

The proposed complex will be built at Vadinar, Gujarat state, where Nayara already operates a refinery, and comprises a 1.8 million t/y steam cracker and downstream units, including aromatics. Overall capacity will be 10.75 million t/y of petrochemicals with completion scheduled in five years’ time.

Nayara is already building a 450,000 t/y PP plant at Vadinar, using Unipol technology from W.R. Grace, as well as a 200,000 t/y methyl tertiary-butyl ether plant. Start-up is scheduled by the end of 2022.

Based in Mumbai, the Indian firm, formerly known as Essar Oil, is 49.13% owned by Russian energy group Rosneft.

 

Author: Elaine Burridge, Freelance Journalist

Shell plans to take a 50% stake and invest up to $9 billion in a petrochemical...
Shell plans to take a 50% stake and invest up to $9 billion in a petrochemical complex planned by Indian oil company Nayara Energy. The proposed complex will be built at Vadinar, Gujarat and comprise a 1.8 million t/y steam cracker and downstream units, including aromatics. (c) Shell

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

most read